Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.59 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.50 |
| ▸ | FPR2 | P25090 | 2/20 | 0.44 |
| ▸ | MEN1 | O00255 | 1/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.44 |
| ▸ | ATM | Q13315 | 1/20 | 0.44 |
| ▸ | MME | P08473 | 2/20 | 0.42 |
| ▸ | ACE | P12821 | 2/20 | 0.42 |
| ▸ | CPA1 | P15085 | 2/20 | 0.42 |
| ▸ | ACE2 | Q9BYF1 | 2/20 | 0.42 |
| ▸ | CA2 | P00918 | 2/20 | 0.41 |
| ▸ | CA1 | P00915 | 1/20 | 0.41 |
| ▸ | ENPEP | Q07075 | 2/20 | 0.40 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.40 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.40 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30552195 | 1.00 | ALDH1A1 (0.59) | ALDH1A1L3MBTL1FPR2MEN1KMT2A | |
| SCHEMBL250457 | 1.00 | ALDH1A1 (0.59) | ALDH1A1L3MBTL1FPR2MEN1KMT2A | |
| SCHEMBL21417705 | 0.84 | ALDH1A1 (0.42) | ALDH1A1L3MBTL1FPR2MEN1KMT2A | |
| SCHEMBL24932734 | 0.84 | ALDH1A1 (0.42) | ALDH1A1L3MBTL1FPR2MEN1KMT2A | |
| SCHEMBL10062994 | 0.84 | ALDH1A1 (0.42) | ALDH1A1L3MBTL1FPR2MEN1KMT2A | |
| SCHEMBL1319707 | 0.83 | SMN1; SMN2 (0.44) | ALDH1A1L3MBTL1MAPK1 | |
| SCHEMBL1319709 | 0.83 | SMN1; SMN2 (0.44) | ALDH1A1L3MBTL1MAPK1 | |
| SCHEMBL16640683 | 0.82 | ALDH1A1 (0.41) | ALDH1A1L3MBTL1FPR2MEN1KMT2A | |
| SCHEMBL12301656 | 0.82 | ALDH1A1 (0.41) | ALDH1A1L3MBTL1FPR2MEN1KMT2A | |
| SCHEMBL14374026 | 0.82 | ALDH1A1 (0.41) | ALDH1A1L3MBTL1FPR2MEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 148 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250268982-A1 | COMPOSITIONS AND METHODS FOR TREATMENT AND/OR PROPHYLAXIS OF PROTEINOPATHIES | REGAIN THERAPEUTICS SWEDEN AB (SE) | 2025-08-28 | — | — | US | claimed |
| EP-4347628-A2 | COMPOSITIONS AND METHODS FOR TREATMENT AND/OR PROPHYLAXIS OF PROTEINOPATHIES | Regain Therapeutics Sweden AB (SE) | 2024-04-10 | — | — | EP | claimed |
| CN-117858892-A | Compositions and methods for treating and/or preventing proteinopathies | 恢复治疗瑞典公司 | 2024-04-09 | — | — | CN | claimed |
| WO-2022248650-A2 | COMPOSITIONS AND METHODS FOR TREATMENT AND/OR PROPHYLAXIS OF PROTEINOPATHIES | REGAIN THERAPEUTICS SWEDEN AB (SE) | 2022-12-01 | — | — | WO | claimed |
| CN-112351818-A | Crystalline salts of 5-methyl- (6S) -tetrahydrofolic acid and ethyl L-isoleucine | 默克专利股份有限公司 | 2021-02-09 | — | — | CN | claimed |
| US-20250295713-A1 | COMPOSITIONS AND METHODS FOR IMPROVING SKIN HEALTH AND FOR THE TREATMENT AND PREVENTION OF DISEASES, DISORDERS AND CONDITIONS ASSOCIATED WITH PATHOGENIC MICROBES | DERMBIONT, INC. | 2025-09-25 | — | — | US | disclosed |
| US-20250268982-A1 | COMPOSITIONS AND METHODS FOR TREATMENT AND/OR PROPHYLAXIS OF PROTEINOPATHIES | REGAIN THERAPEUTICS SWEDEN AB (SE) | 2025-08-28 | — | — | US | disclosed |
| US-12064459-B2 | Compositions and methods for improving skin health and for the treatment and prevention of diseases, disorders and conditions associated with pathogenic microbes | DERMBIONT, INC. (US) | 2024-08-20 | — | — | US | disclosed |
| US-20240182532-A1 | MICROPEPTIDES AND USES THEREOF | FUNDACIÓ PRIVADA INSTITUT D'INVESTIGACIÓ ONCOLÒGICA DE VALL HEBRON (ES) | 2024-06-06 | — | — | US | disclosed |
| EP-4347628-A2 | COMPOSITIONS AND METHODS FOR TREATMENT AND/OR PROPHYLAXIS OF PROTEINOPATHIES | Regain Therapeutics Sweden AB (SE) | 2024-04-10 | — | — | EP | disclosed |
| CN-117858892-A | Compositions and methods for treating and/or preventing proteinopathies | 恢复治疗瑞典公司 | 2024-04-09 | — | — | CN | disclosed |
| US-11858972-B2 | Micropeptides and uses thereof | FUNDACIÓ PRIVADA INSTITUT D'INVESTIGACIÓ ONCOLÒGICA DE VALL HEBRON (ES) | 2024-01-02 | — | — | US | disclosed |
| US-20080305471-A1 | polypeptides comprising an amino acid sequence of a photocatalytic unit of a photosynthetic microorganism, capable of maintaining photocatalytic activity when attached to solid surfaces of electrooptic devices | RAMOT AT TEL AVIV UNIVERSITY LTD. (IL) | 2008-12-11 | — | — | US | disclosed |
| EP-1677816-A1 | THERAPEUTIC METHOD | MONASH UNIVERSITY (AU) | 2006-07-12 | — | — | EP | disclosed |
| WO-2005032578-A1 | THERAPEUTIC METHOD | MONASH UNIVERSITY (AU) | 2005-04-14 | — | — | WO | disclosed |
| CN-1211188-A | Urogenital and intestinal compositions | PROCTER & GAMBLE (US) | 1999-03-17 | — | — | CN | disclosed |
| CN-1211189-A | Urogenital and intestinal disorder compositions comprising a substrance derived from plant species of the ericaceae family and a lactic acid bacteria growth factor | PROCTER & GAMBLE (US) | 1999-03-17 | — | — | CN | disclosed |
| EP-0880354-A1 | UROGENITAL AND INTESTINAL COMPOSITIONS | THE PROCTER & GAMBLE COMPANY (US) | 1998-12-02 | — | — | EP | disclosed |
| WO-1997029762-A1 | UROGENITAL AND INTESTINAL COMPOSITIONS | THE PROCTER & GAMBLE COMPANY (US) | 1997-08-21 | — | — | WO | disclosed |
| EP-0642530-A1 | DERIVATIVES OF DOLASTATIN | BASF Aktiengesellschaft (DE) | 1995-03-15 | — | — | EP | disclosed |